Companies
Addgene
Plasmid Repository — Automated distribution.
- Country
- United States
Coverage
| CN | EU | US | |
|---|---|---|---|
| foundries-design | ✓ | ✓ | ✓ |
Regulatorsepa
Verifiable facts
| Fact | Value | Source |
|---|---|---|
| Funding | $137,464 grant from Allen Institute (2024-12) and $520,667 research grant from The Broad Institute (2025-06) | causeiq.com |
| Headcount | 154 employees | projects.propublica.org · siviq.co · causeiq.com |
| Revenue | $26,391,816 for the fiscal year ending December 2024 | projects.propublica.org · siviq.co · causeiq.com |
| Headquarters | Watertown, Massachusetts, USA | projects.propublica.org · causeiq.com · massbio.org |
| Regulatory approval | Export licenses required for certain dual-use materials via the U.S. Bureau of Industry and Security; specific import permits required for international shipments to certain countries | help.addgene.org |
Independent sources: causeiq.com · massbio.org · projects.propublica.org · siviq.co
Technologies
| Name | Cluster | Risk | |
|---|---|---|---|
| iGEM infrastructure, BioBricks and standard genetic parts | foundries-design | Low | → |
Compiled by BIOECON from primary sources.
Compliance
Bioecon is an information intermediary; it is not a regulator, a certification body, or a legal advisor. When working with public-sector customers (procurement under 44-FZ / 223-FZ), Bioecon acts solely as an independent analytical platform, with no remuneration from suppliers.